Cocaine and other drugs of abuse hijack the natural reward circuits in the brain. In part, that's why it's so hard to quit using these substances. Moreover, relapse rates hover between 40 and 60 percent, similar to rates ...
Apr 28, 2018
1
312
A research team at the University of Maryland School of Medicine has identified a cell signaling pathway which plays a significant role in causing developmental defects of the fetal spinal cord and brain in babies of women ...
Aug 28, 2013
0
0
Cartilage injury is a common cause of joint dysfunction and existing joint prostheses cannot remodel with host joint tissue. However, it is challenging to develop large-scale biomimetic anisotropic constructs that structurally ...
The most common type of hypertension, which accounts for 95 per cent of people with high blood pressure, might one day be prevented with breathing exercises if caught early enough.
Apr 27, 2017
2
241
Schizophrenia, an often severe and disabling psychiatric disorder, affects approximately 1 percent of the world's population. While research over the past few years has suggested that desynchronization of neurons may be the ...
Sep 17, 2018
0
1055
Rats with regular access to cannabis seek more of the substance and tend to show increased drug-seeking behavior when cannabis is absent.
Mar 24, 2020
5
1126
For decades, neuroscientists and physicians have tried to get to the bottom of the age-old mystery of post-traumatic stress disorder, to explain why only some people are vulnerable and why they experience so many symptoms ...
Oct 7, 2016
4
232
The hepatitis C virus hijacks the body's immune system, leaving T cells unable to function. A new study in animal models suggests that blocking a protein that helps the virus thrive could restore immune function, allowing ...
Sep 3, 2013
0
0
A new study from Western's Schulich School of Medicine & Dentistry and collaborators from West China Hospital in Chengdu, is challenging long-held notions about brain deterioration in patients with psychotic disorders, and ...
Feb 16, 2022
1
102
Immunobiologists in China have designed a synthetic T cell receptor for anticancer therapy, engineering the protein not only with a capability to seek and destroy solid tumors, but endowing this cancer fighting weapon with ...
